Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06816992 |
| Title | ORIC-114 in Combination with Subcutaneous Amivantamab in Patients with EGFR Exon20 Insertion Mutant NSCLC |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | ORIC Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope | NOT_YET_RECRUITING | Duarte | California | 91010 | United States | Details |
| NYU Langone Health | RECRUITING | New York | New York | 10016 | United States | Details |
| Virginia Cancer Specialists | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |
| Peter MacCallum Cancer Centre | NOT_YET_RECRUITING | Melbourne | Victoria | 03000 | Australia | Details |
| The Princess Margaret Hospital | NOT_YET_RECRUITING | Toronto | Ontario | M5G 1Z5 | Canada | Details |